Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/50322

TitlePaclitaxel pharmaceutical profiling aiming the optimization of a novel lipid nanotherapy
Author(s)Carvalho, Ana M.
Demaitre, Justine
Real Oliveira, M. Elisabete C. D.
Lúcio, M.
Nieder, Jana
Issue date2016
Abstract(s)Paclitaxel (PTX) is a cytostatic anticancer drug used extensively in wide types of cancer. Due to its lipophilic nature (Kp(water/n-octanol) = 3.54) PTX needs a vehicle for its administration. The current vehicles used to improve PTX solubilisation and administration, however they present toxicity promoting side-effects. Moreover, the lipophilic nature of paclitaxel may have an important role on drug distribution and, consequently, on systemic toxicity, by interacting with amphiphilic molecules, such as lipids and transporter proteins. In this study, it is intended to characterize the interactions of paclitaxel with biological interfaces in a biophysical point of view, in order to predict the absorption, distribution, metabolism, elimination and toxicity (ADMET) of free paclitaxel. Paclitaxel partition coefficient in liposomes/water system under physiological conditions was determined by derivative spectroscopy, paclitaxel effect on membrane viscosity was determined by dynamic light scattering and fluorescence anisotropy, fluorescence quenching studies were used to determine paclitaxel location in cell membrane model (KSV and KD) and determine HAS-paclitaxel binding constant (Kb).
TypeOral presentation
URIhttp://hdl.handle.net/1822/50322
Peer-Reviewedyes
AccessRestricted access (UMinho)
Appears in Collections:CDF - FAMO - Comunicações/Communications (with refereeing)

Files in This Item:
File Description SizeFormat 
Ana_Carvalho_poster+oral.pdf
  Restricted access
303,96 kBAdobe PDFView/Open    Request a copy!

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID